SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-017680
Filing Date
2019-08-30
Accepted
2019-08-30 10:07:14
Documents
22
Period of Report
2019-08-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20190828_8k.htm 8-K 23027
2 INVESTOR PRESENTATION ex_156660.htm EX-99.1 12018
3 slide01.jpg GRAPHIC 144072
4 slide02.jpg GRAPHIC 243635
5 slide03.jpg GRAPHIC 167730
6 slide04.jpg GRAPHIC 202290
7 slide05.jpg GRAPHIC 126019
8 slide06.jpg GRAPHIC 159943
9 slide07.jpg GRAPHIC 167461
10 slide08.jpg GRAPHIC 136425
11 slide09.jpg GRAPHIC 172395
12 slide10.jpg GRAPHIC 140667
13 slide11.jpg GRAPHIC 139564
14 slide12.jpg GRAPHIC 180551
15 slide13.jpg GRAPHIC 187702
16 slide14.jpg GRAPHIC 206171
17 slide15.jpg GRAPHIC 154020
18 slide16.jpg GRAPHIC 232272
19 slide17.jpg GRAPHIC 192902
20 slide18.jpg GRAPHIC 154678
21 slide19.jpg GRAPHIC 147714
22 slide20.jpg GRAPHIC 83874
  Complete submission text file 0001437749-19-017680.txt   4635315
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 191068051
SIC: 2834 Pharmaceutical Preparations